dpk-060
Peptideexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT01522391)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dpk-060
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01447017 | Phase 2 | Nov 1, 2011 | DermaGen AB, Pergamum AB, Probare i Lund AB, University of Gothenburg |
| NCT01522391 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | DermaGen AB |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DermaGen AB | For profit | 2 | 2 | 1 | 2008 |
| Pergamum AB | For profit | 1 | 0 | 1 | 2011 |
| Probare i Lund AB | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1